IL33 and melanoma: Research has shown that eosinophil depletion markedly reduces the anti-melanoma effects mediated by IL-33, along with the recruitment and activation levels of CD8+ T cells and NK cells 64, which suggests that eosinophils can enhance T cell activity, thereby indirectly inhibiting the growth of primary tumors.